Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell–like and non–germinal center B-cell–like subtypes of diffuse …
K Fu, DD Weisenburger, WWL Choi… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell–like [GCB] and activated B-cell–like [ABC] …
important subtypes (ie, germinal center B-cell–like [GCB] and activated B-cell–like [ABC] …
[引用][C] Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell-Like and Non-Germinal Center B-Cell-Like …
KAI FU, DD WEISENBURGER… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the
Germinal Center B-Cell-Like and Non-Germinal Center B-Cell-Like Subtypes of Diffuse …
Germinal Center B-Cell-Like and Non-Germinal Center B-Cell-Like Subtypes of Diffuse …
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse …
K Fu, DD Weisenburger, WWL Choi… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse …
K Fu, DD Weisenburger, WW Choi… - Journal of Clinical …, 2008 - europepmc.org
Purpose Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
[PDF][PDF] Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like …
K Fu, DD Weisenburger, WWL Choi, KD Perry… - Clinical …, 2007 - researchgate.net
Purpose Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell–like [GCB] and activated B-cell–like [ABC] …
important subtypes (ie, germinal center B-cell–like [GCB] and activated B-cell–like [ABC] …
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse …
K Fu, DD Weisenburger, WWL Choi… - Journal of Clinical …, 2008 - experts.nebraska.edu
Purpose: Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
Addition of Rituximab to Standard Chemotherapy Improves the Survival of Both the Germinal Center B-Cell–Like and Non–Germinal Center B-Cell–Like Subtypes of …
K Fu, DD Weisenburger, WWL Choi, KD Perry… - Journal of Clinical …, 2008 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Diffuse large B-cell lymphoma
(DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell …
(DLBCL) includes at least two prognostically important subtypes (ie, germinal center B-cell …
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse …
K Fu, DD Weisenburger, WWL Choi, KD Perry… - Journal of Clinical …, 2008 - hub.hku.hk
Purpose: Diffuse large B-cell lymphoma (DLBCL) includes at least two prognostically
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
important subtypes (ie, germinal center B-cell-like [GCB] and activated B-cell-like [ABC] …
[引用][C] Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of …
K FU - J Clin Oncol., 2008 - cir.nii.ac.jp
Addition of rituximab to standard chemotherapy improves the survival of both the germinal
center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma …
center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma …